Progenesis
Fernanda Pacheco serves as the Director of Medical Affairs at Progenesis since 2022, where Fernanda was instrumental in the company's expansion into the Brazilian market by establishing connections with medical professionals and overseeing the internationalization process. In addition to her role at Progenesis, Fernanda holds positions in multiple healthcare settings in São Paulo, including Livance, Centro de Reprodução Humana Nilo Frantz, and various hospitals, specializing in gynecology, human reproduction, and obstetrics since 2005. Fernanda's educational background includes a Master's degree in Biotechnology and Entrepreneurship from NYU Tandon School of Engineering, a fellowship in Fertility Preservation, and an MBA in Health Business Management, complemented by a medical degree from the Pontifícia Universidade Católica do Rio Grande do Sul.
This person is not in any teams
This person is not in any offices
Progenesis
1 followers
Progenesis is the first company in the US to introduce Next Generation Sequencing (NGS) for Preimplantation Genetic Testing for Aneuploidy (PGT-A) and Preimplantation Genetic Testing for Monogenic disorders (PGT-M). We offer embryo screening for many common diseases including cystic fibrosis, Fragile X syndrome, sickle cell disease, and Tay-Sachs disease. We have introduced the most accurate test in the IVF field for 24-chromosome aneuploidy screening and single gene disorder. At Progenesis, we believe in innovation. Our expert scientists are constantly working to improve our products through research and development. Our goal is to provide our patients with the latest, most advanced technology and information to equip them with the best tools to build healthy families. For more information, please visit www.progenesis.com. #Progenesis #Biotechnology #GeneticTesting #Innovation #IVF #Infertility #Diagnosis